Clinical trials
Phase 1 Diabetes Mellitus, Type 1 trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Terminated | 3 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 4 |
| University of Alberta | 4 |
| CRISPR Therapeutics AG | 2 |
| Encellin | 2 |
| Canadian Diabetes Association | 1 |
| ClinSurge Research | 1 |
| Dr. Paul F. Gratzer | 1 |
| McGill University | 1 |
| Neurocrine Biosciences | 1 |
| University of Calgary | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 1 | 21 |
| Diabetes Mellitus | 7 |
| Diabetes Mellitus, Type 2 | 3 |
| Autoimmune Diseases | 2 |
| Endocrine System Diseases | 2 |
| Glucose Metabolism Disorders | 2 |
| Hypoglycemia | 2 |
| Immune System Diseases | 2 |
| Metabolic Diseases | 2 |
| Insulin Resistance | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.